Syndax Pharmaceuticals Inc (SNDX) Ownership

23.80 ↑0.73 (3.16%)
As of March 28, 2024, 3:59pm EST.

Institutional Ownership

Wellington Management Company LLP is the biggest individual institutional holder of Syndax Pharmaceuticals Inc (SNDX), owning a total of 7.6 million shares. Combined, the top 36 institutional holders of SNDX own 104.17% of the company with a total of 85.6 million shares.

In the latest ownership report on December 31st 2023, the top 36 institutional holders increased their combined ownership of SNDX by 20.1 million shares. 17 institutions bought 20,171,967 total additional shares and increased their ownership by an average of 320.90%. However 1 institutions sold 57,225 total shares and decreased their ownership by an average of 0.75%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Syndax Pharmaceuticals increased by a net total of 20,114,742 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Wellington Management Company LLP8.927%-0.749%7,585,221-57,2252023-12-31
BlackRock Inc8.257%19.259%7,015,5481,132,9122023-12-31
Kynam Capital Management, LP6.662%57.222%5,660,0002,060,0002023-12-31
State Street Corporation5.904%39.315%5,016,2241,415,5762023-12-31
Vanguard Group Inc5.103%19.851%4,335,353718,0512023-12-31
venBio Select Advisor LLC4.969%65.217%4,222,2221,666,6672023-12-31
Avidity Partners Management LP4.649%40.021%3,950,0001,129,0002023-12-31
Eversept Partners, LLC3.982%30.313%3,383,244786,9992023-12-31
T. Rowe Price Investment Management,Inc.3.191%154.208%2,711,2531,644,7052023-12-31
Goldman Sachs Group Inc2.945%97.350%2,501,8961,234,1482023-12-31
Marshall Wace Asset Management Ltd2.474%248.020%2,101,9111,497,9492023-12-31
Orbimed Advisors, LLC2.059%36.215%1,749,000465,0002023-12-31
Morgan Stanley - Brokerage Accounts1.959%202.585%1,664,3061,114,2772023-12-31
Woodline Partners LP1.818%4,432.880%1,544,2161,510,1492023-12-31
Geode Capital Management, LLC1.807%12.795%1,535,055174,1352023-12-31
Franklin Resources Inc1.592%0.000%1,352,9051,352,9052023-12-31
Cormorant Asset Management, LLC1.383%0.000%1,175,0001,175,0002023-12-31
StemPoint Capital LP1.288%0.000%1,094,4941,094,4942023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Wellington Management Company LLP8.927%-0.749%7,585,221-57,2252023-12-31
BlackRock Inc8.257%19.259%7,015,5481,132,9122023-12-31
Kynam Capital Management, LP6.662%57.222%5,660,0002,060,0002023-12-31
State Street Corporation5.904%39.315%5,016,2241,415,5762023-12-31
Vanguard Group Inc5.103%19.851%4,335,353718,0512023-12-31
venBio Select Advisor LLC4.969%65.217%4,222,2221,666,6672023-12-31
Avidity Partners Management LP4.649%40.021%3,950,0001,129,0002023-12-31
Eversept Partners, LLC3.982%30.313%3,383,244786,9992023-12-31
Partner Fund Management LP3.196%24.986%2,715,235542,7982023-09-30
T. Rowe Price Investment Management,Inc.3.191%154.208%2,711,2531,644,7052023-12-31
Goldman Sachs Group Inc2.945%97.350%2,501,8961,234,1482023-12-31
Hudson Bay Capital Management LP2.915%420.499%2,472,3721,997,3722023-09-30
Paradigm Biocapital Advisors LP2.818%-1.405%2,390,077-34,0552023-09-30
Jennison Associates LLC2.768%-6.909%2,347,673-174,2432023-09-30
Bvf Inc3.084%47.685%2,143,197692,0002023-03-31
Marshall Wace Asset Management Ltd2.474%248.020%2,101,9111,497,9492023-12-31
Point72 Asset Management, L.P.2.465%69.598%2,094,201859,4012023-09-30
Orbimed Advisors, LLC2.059%36.215%1,749,000465,0002023-12-31
Morgan Stanley - Brokerage Accounts1.959%202.585%1,664,3061,114,2772023-12-31
Citadel Advisors Llc2.273%-2.960%1,579,669-48,1842023-03-31
Woodline Partners LP1.818%4,432.880%1,544,2161,510,1492023-12-31
Geode Capital Management, LLC1.807%12.795%1,535,055174,1352023-12-31
Franklin Resources Inc1.592%0.000%1,352,9051,352,9052023-12-31
Dimensional Fund Advisors, Inc.1.900%4.273%1,320,22554,0962023-03-31
Cormorant Asset Management, LLC1.383%0.000%1,175,0001,175,0002023-12-31
Sphera Funds Management Ltd.1.892%-10.810%1,139,329-138,0842022-06-30
683 Capital Management LLC1.659%-28.556%1,130,000-451,6532022-09-30
StemPoint Capital LP1.288%0.000%1,094,4941,094,4942023-12-31
Aisling Capital Management LP1.209%0.000%1,025,00002023-09-30
Adage Capital Partners Gp LLC1.179%8.108%1,000,00075,0002023-09-30
Barclays PLC1.413%1.926%981,88618,5502023-03-31
Nantahala Capital Management, LLC1.404%0.000%975,70502023-03-31
COMMODORE CAPITAL LP1.129%-4.018%957,509-40,0872023-09-30
Sofinnova Ventures1.111%-40.478%941,817-640,4742023-09-30
Healthcor Management LP1.536%-21.779%923,400-257,1002022-06-30
Foresite Capital Management IV, LLC1.257%0.000%875,00002023-06-30

Mutual Fund Ownership

Vanguard Health Care Inv is the biggest individual fund holder of Syndax Pharmaceuticals Inc (SNDX), owning a total of 4.2 million shares. Combined, the top 40 mutual fund holders of SNDX own 39.89% of the company with a total of 32.6 million shares.

In the latest ownership report on February 29th 2024, the top 40 fund holders increased their combined ownership of SNDX by 55 thousand shares. 1 funds bought 70,860 total additional shares and increased their ownership by an average of 1.90%. However 5 funds sold 16,255 total shares and decreased their ownership by an average of 0.23%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Syndax Pharmaceuticals increased by a net total of 54,605 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF4.462%1.905%3,791,37470,8602024-02-29
Vanguard Total Stock Mkt Idx Inv2.816%-0.485%2,392,625-11,6542024-02-29
iShares Russell 2000 ETF1.919%-0.016%1,630,808-2672024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.329%-0.100%1,129,060-1,1352024-02-29
Belfius Equities Cure C Cap0.772%0.000%656,00002024-02-29
iShares Biotechnology ETF0.688%-0.448%584,228-2,6302024-02-29
iShares Russell 2000 Growth ETF0.576%-0.116%488,964-5692024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Health Care Inv5.001%37.427%4,249,3521,157,2702023-12-31
SPDR® S&P Biotech ETF4.462%1.905%3,791,37470,8602024-02-29
Vanguard Total Stock Mkt Idx Inv2.816%-0.485%2,392,625-11,6542024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr2.868%3.667%1,997,38570,6602023-03-31
iShares Russell 2000 ETF1.919%-0.016%1,630,808-2672024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.329%-0.100%1,129,060-1,1352024-02-29
Vanguard Extended Market Index Investor1.283%-0.022%891,736-1932023-08-31
T. Rowe Price Small-Cap Value1.034%36.542%878,100235,0002023-12-31
Wellington Global Hlthcr Eq USD G Ac0.960%-1.192%815,506-9,8402024-01-31
Fidelity Small Cap Index0.783%2.707%665,12517,5332023-12-31
Jennison SMid Cap Core Equity0.774%-14.497%656,761-111,3552023-09-30
PGIM Jennison Small Company A0.943%-14.497%656,761-111,3552023-09-30
Belfius Equities Cure C Cap0.772%0.000%656,00002024-02-29
Candriam Global Equities Oncology0.772%173.333%656,000416,0002023-12-31
Fidelity® Small Cap Index0.748%2.559%634,69715,8382023-10-31
Franklin Biotechnology Discv A(acc)USD0.704%0.000%598,10002024-01-31
iShares Biotechnology ETF0.688%-0.448%584,228-2,6302024-02-29
Jennison Health Sciences Equity0.677%0.000%573,84802023-09-30
PGIM Jennison Health Sciences Z0.824%0.000%573,84802023-09-30
T. Rowe Price US Small-Cap Core Equity0.583%0.000%495,254495,2542023-12-31
T. Rowe Price Small-Cap Stock0.583%0.000%495,254495,2542023-12-31
iShares Russell 2000 Growth ETF0.576%-0.116%488,964-5692024-02-29
Biotech Growth Ord0.569%40.816%483,000140,0002023-11-30
iShares Russell 2000 Value ETF0.677%0.562%465,7642,6012023-06-21
Franklin US Small Cap Growth Equity0.512%0.000%434,900434,9002023-12-31
Franklin Small Cap Growth Adv0.512%0.000%434,90002024-01-31
Direxion Daily S&P Biotech Bull 3X ETF0.506%3.801%429,31715,7202023-12-28
Fidelity Extended Market Index0.502%1.136%426,3434,7892024-01-31
Candriam Eqs L Biotech C USD Cap0.488%13.699%415,00050,0002024-01-31
BlackRock Advantage Small Cap Core Instl0.481%-14.898%407,489-71,3342023-12-31
T. Rowe Price U.S. SC Value Eq Tr-Z0.479%45.019%405,854125,9922023-12-31
Columbia Small Cap Growth SMA Cmp0.473%34.037%401,061101,8442023-10-31
Columbia Small Cap Growth Inst0.473%0.000%401,06102023-11-30
Columbia Small Cap Growth0.576%34.037%401,061101,8442023-10-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.456%5.622%387,03620,6002023-12-31
Fidelity® Extended Market Index0.444%0.000%376,26202023-11-30
Schwab US Small-Cap ETF™0.408%0.044%346,3391532023-12-30
DFA US Micro Cap I0.491%-12.994%337,718-50,4382023-04-30
DFA US Small Cap I0.451%-15.741%310,558-58,0192023-04-30
State St Russell Sm Cap® Indx SL Cl I0.290%0.000%245,49502023-12-31

Discussions

Please log in or register to share your thoughts.

beardedstocks

$SNDX I actually want the market pullback 5% is pretty crazy how this market keep going and going

0 Like Report
145zip

$SNDX glad I didn’t chase this isn’t moving anytime soon with all of those call options here lol

0 Like Report